Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bar

Showing results (101-110 of 106) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 106 results.
Journal of the National Cancer Institute|July 17, 1998
Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumorsW H Gotlieb, E Friedman, R B Bar-Sade, et al.
Harefuah|July 27, 2000
[Experience at Sheba Hospital in oncogenetic counseling and genetic testing of women with a high risk for breast and ovarian cancer]L Theodor, R Shiri-Sverdlov, G H Yechezkel, et al.
Human Molecular Genetics|May 23, 1998
The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to AshkenazimR B Bar-Sade, A Kruglikova, B Modan, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2000
Immunohistochemical analyses of sporadic and familial (185delAG carriers) ovarian cancer in IsraelA Ravid, I Barshack, G Hirsh-Yechezkel, et al.
Human Mutation|January 11, 2000
Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancerR Shiri-Sverdlov, P Oefner, L Green, et al.
Lymphology|January 25, 2013
Congenital fetal and neonatal visceral chylous effusions: neonatal chylothorax and chylous ascites revisited. A multicenter retrospective studyC Bellini, Z Ergaz, M Radicioni, et al.
Pageof 11

Showing results (101-110 of 106) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 106 results.
Journal of the National Cancer Institute|July 17, 1998
Rates of Jewish ancestral mutations in BRCA1 and BRCA2 in borderline ovarian tumorsW H Gotlieb, E Friedman, R B Bar-Sade, et al.
Harefuah|July 27, 2000
[Experience at Sheba Hospital in oncogenetic counseling and genetic testing of women with a high risk for breast and ovarian cancer]L Theodor, R Shiri-Sverdlov, G H Yechezkel, et al.
Human Molecular Genetics|May 23, 1998
The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to AshkenazimR B Bar-Sade, A Kruglikova, B Modan, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2000
Immunohistochemical analyses of sporadic and familial (185delAG carriers) ovarian cancer in IsraelA Ravid, I Barshack, G Hirsh-Yechezkel, et al.
Human Mutation|January 11, 2000
Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancerR Shiri-Sverdlov, P Oefner, L Green, et al.
Lymphology|January 25, 2013
Congenital fetal and neonatal visceral chylous effusions: neonatal chylothorax and chylous ascites revisited. A multicenter retrospective studyC Bellini, Z Ergaz, M Radicioni, et al.
Pageof 11